What 8 Analyst Ratings Have To Say About Gilead Sciences

BenzingaJun 14 12:00 ET

Amgen Analyst Ratings

BenzingaJun 14 09:32 ET

Ionis Pharmaceuticals Analyst Ratings

BenzingaJun 14 05:54 ET

Neurocrine Biosciences Analyst Ratings

BenzingaJun 12 13:02 ET

Wells Fargo Adjusts Price Target on Regeneron Pharmaceuticals to $1,125 From $1,050

MT NewswiresJun 12 08:18 ET

Regeneron Pharmaceuticals Analyst Ratings

BenzingaJun 12 07:51 ET

Research Alert: CFRA Adds Amgen Inc. To The High-quality Capital Appreciation Portfolio

MT NewswiresJun 12 00:20 ET

Illumina Analyst Ratings

BenzingaJun 11 08:43 ET

Evercore ISI Cuts Price Target on Illumina to $175 From $195

MT NewswiresJun 11 08:24 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 11 07:34 ET

RBC Adjusts Price Target on Vertex Pharmaceuticals to $421 From $424

MT NewswiresJun 11 05:24 ET

Wells Fargo Adjusts Price Target on Halozyme Therapeutics to $58 From $48, Maintains Overweight Rating

MT NewswiresJun 7 09:21 ET

Halozyme Downgraded at Piper Sandler Despite Guidance Raise

Seeking AlphaJun 7 09:16 ET

Halozyme Therapeutics Analyst Ratings

BenzingaJun 7 05:19 ET

Illumina Analyst Ratings

BenzingaJun 6 12:32 ET

TD Cowen Adjusts Price Target on Illumina to $122 From $140

MT NewswiresJun 6 06:38 ET

Nephron Research Upgrades Illumina to Hold, Price Target at $100

MT NewswiresJun 5 07:33 ET

Regeneron Pharmaceuticals Analyst Ratings

BenzingaJun 4 09:50 ET

Vertex Pharmaceuticals Analyst Ratings

BenzingaJun 4 09:48 ET

Halozyme Therapeutics Analyst Ratings

BenzingaJun 4 06:27 ET